Biotech

All Articles

Zephyrm finds Hong Kong IPO to fund phase 3 cell treatment tests

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock market, submitting (PDF) for an I...

Frazier Lifestyle Sciences gathers $630M for small, mid-cap biotechs

.Frazier Lifespan Sciences has sourced a better $630 thousand for its own fund focused on small as w...

GigaGen amasses approximately $135M BARDA bucks to beat botulism

.Antibody enthusiast GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its specialist ...

GPCR firm Septerna apply for IPO on durability of preclinical information

.Septerna is about to learn exactly how a biotech without "any relevant scientific records" meals in...

Kurma finalizes first $154M haul for biggest biotech fund yet

.European VC organization Kurma Partners has unveiled its newest biotech fund, along with 140 millio...

Prothena promotes one exec while an additional places-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable management hirings, firings and re...

Editas exploit Vertex Cas9 licensing civil rights for $57M

.Versus the background of a Cas9 patent battle that declines to pass away, Editas Medicine is actual...

Ultragenyx tweaks gene treatment application to call up effectiveness

.A minority of clients taking Ultragenyx Drug's Wilson disease gene treatment UX701 have actually go...

Biopharma unemployment cost maintains in Q3: Fierce Biotech analysis

.As summer warm counts on cool down winds, wishes that this year would carry extensive business reli...

J &amp J falls stage 2 dengue prospect in most current shift from vaccinations

.Johnson &amp Johnson's deprioritization of its own contagious illness pipeline has asserted one mor...